Ultrasound-guided thrombin injection in the management of pseudoaneurysm after percutaneous arterial access

Tomasz Jargiełło1, Jan Sobstyl1, Łukasz Światłowski1, Maryla Kuczyńska1, Ewa Kuklik1, Michał Sojka1, Anna Drelich-Zbroja1, Maciej Pech2, Maciej Powerski2
Affiliation and address for correspondence
J Ultrason 2018; 18: 85–89
DOI: 10.15557/JoU.2018.0012
PlumX metrics:

Aim: The purpose of this paper was to evaluate the efficacy of ultrasound-guided percutaneous thrombin injection as a treatment method for arterial access site pseudoaneurysm. Materials and methods: A total of 148 patients with iatrogenic arterial access site pseudoaneurysms were treated in the Department of Interventional Radiology and Neuroradiology, Medical University of Lublin. Of those, 142 pseudoaneurysms were located in the common femoral artery, 3 in the brachial artery and the remaining 3 in the radial artery. The study included 77 woman and 71 men (mean age 64.5 ± 14 years). Patients were qualified for percutaneous thrombin injection after Doppler examination during which pseudoaneurysm size and morphology were assessed as well as the presence of arteriovenous fistula was excluded. Results: In the reported study, 94.8% (128/135) of patients were successfully treated during the initial thrombin injection. Additional 400 IU dose of thrombin after 24 hours was effective in 5 out of 7 patients with recanalization during the follow-up. A total of 98.5% (133/135) of patients were successfully treated with a percutaneous ultrasound-guided thrombin injection. Conclusions: The 10-year experience presented in this study as well as literature reports prove that percutaneous ultrasound-guided thrombin injection is an effective and safe treatment method for iatrogenic arterial access site pseudoaneurysm.

interventional ultrasonography, thrombin, pseudoaneurysm